Rapid Bilateral Vision Loss due to Giant Cell Arteritis: A Case Series Highlighting the Need for Aggressive Inpatient Management
Marcos Flores Valdés1, Anisha Dash2, Safwan Hyder1, Kevin Gurrala2, Jano Janoyan2
1Neurology, 2Internal Medicine, University of Tennessee Health Science Center College of Medicine, Knoxville (UTHSC COM-Knoxville)
Objective:
To present two cases of Giant Cell Arteritis (GCA) resulting in rapid bilateral vision loss and to highlight the importance of prompt, aggressive inpatient treatment even in atypical cases.
Background:
GCA, also known as temporal arteritis, is a vasculitis of large- and medium-sized vessels that primarily affect individuals over 50 years old, peaking between 70 and 79 years. It can cause systemic inflammation, leading to vascular stenosis and aneurysm formation. Vision loss is the most feared complication and is often irreversible. Permanent partial or complete visual loss occurs in 8–20% of patients, and if untreated, up to 50% may experience vision loss in the contralateral eye. Early recognition and immediate high-dose corticosteroid therapy are critical to prevent progression.
Design/Methods:
Case series
Results:
Case 1: A 76-year-old woman presented with several weeks of bilateral blurry vision followed by acute, painless vision loss. This was evaluated by ophthalmologists as an outpatient and no steroids were given. She denied headaches, jaw claudication, or scalp tenderness. Laboratory evaluation revealed markedly elevated inflammatory markers. Despite inpatient high-dose IV steroids and heparin for progressive ischemia, she developed complete bilateral blindness by hospital day four. Temporal artery biopsy confirmed by GCA.
Case 2: An 88-year-old woman presented with six days of painless, progressive vision loss. She had been on an outpatient prednisone taper (starting at 40 mg daily) for presumed GCA while waiting for the temporal biopsy results. Despite inpatient high-dose IV steroids, her partial left-eye vision deteriorated to complete bilateral blindness within 24 hours.
Conclusions:
These cases highlight the devastating visual outcomes of GCA despite aggressive treatment after the visual symptoms have progressed. Early recognition and initiation of high-dose corticosteroids in the inpatient setting are essential. Color Doppler ultrasonography (CDUS) should be considered a faster diagnostic adjunct when we can’t wait for biopsy confirmation.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.